PETMUNIOME
Advanced Immune Support for Dogs and Cats
Supports immune resilience by detoxifying metabolic waste and restoring systemic balance beyond symptom management.
An innovative solution for intractable pet conditions
clinically validated by the Seoul National University Veterinary Integrative Medicine Research Center.
PETMUNIOME and KIDNIOME work together to simultaneously support the Gut–Immune–Kidney
Tri-Axes for comprehensive, root-cause care.
PETMUNIOME
PETMUNIOME is an immune-support product that demonstrated an average improvement of 28.9% across 11 biomarkers in a 3-month clinical study involving four dogs with end-stage cancer.
| Category | Outcome | Details |
|---|---|---|
| Key Biomarkers (11 total) | Average improvement: 28.9% | Lymphocytes +48.2%, CRP +21.3% |
| Immune Markers | 33.2% improvement | WBC, Lymphocyte, CRP |
| Renal Markers | 31.2% improvement | Creatinine, BUN, UPC, Albumin |
| Metabolic Markers | 23.3% improvement | Glucose, Total Protein, Amylase, Lipase |
| Average Body Weight | +2.8% maintained/increased | 6.45 kg → 6.63 kg |
| Clinical Observations | Qualitative improvement | Improved appetite and increased activity levels |
- Source: Seoul National University Veterinary Integrative Medicine Research Center / 3-month clinical data
- Published in Applied Biological Chemistry (October 20230
MMT eliminates toxic metabolic byproducts, simultaneously
restores Tri-Axes interactions, enhances therapeutic effectiveness
Minimizes the risk of complications
PETMUNIOME Post-Administration
Improvement Rates
Key Ingredients of PETMUNIOME
Uses natural ingredients validated by SCI-level research publications
Immune Enhancement, Anti-Cancer & Anti-Inflammatory Effects, Activation of the Gut–Immune Axis
Supports overall systemic condition while targeting cancer cells specifically, enhancing immunity, reducing inflammation, and activating the Gut–Immune Axis.